Loss of Interleukin-10 Signaling and Infantile Inflammatory Bowel Disease: Implications for Diagnosis and Therapy

2012/04/30 by Daniel Kotlarz, Rita Beier, Dhaarini Murugan +41 · 28 citations
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · #Inflammatory Bowel Disease #T-cell and B-cell Immunology #Immune Response and Inflammation

paper · pdf · doi:10.1053/j.gastro.2012.04.045

Cited by

• Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency
• The clinical, molecular, and therapeutic features of patients with IL10/IL10R deficiency: a systematic review
• Autoinflammatory diseases in childhood, part 2: polygenic syndromes
• Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. [europepmc]
• Monogenic autoinflammatory diseases: concept and clinical manifestations. [europepmc]
• Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells. [europepmc]
• Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. [europepmc]
• Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans. [europepmc]
• Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage. [europepmc]
• Innate and adaptive immune interactions at the fetal-maternal interface in healthy human pregnancy and pre-eclampsia. [europepmc]
• Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. [europepmc]
• The diagnostic approach to monogenic very early onset inflammatory bowel disease. [europepmc]
• Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4. [europepmc]
• Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. [europepmc]
• Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family. [europepmc]
• Genetics and Pathogenesis of Inflammatory Bowel Disease. [europepmc]
• Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency. [europepmc]
• IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function. [europepmc]
• Human TGF-β1 deficiency causes severe inflammatory bowel disease and encephalopathy. [europepmc]
• Hookworm Secreted Extracellular Vesicles Interact With Host Cells and Prevent Inducible Colitis in Mice. [europepmc]
• Molecular and functional heterogeneity of IL-10-producing CD4 + T cells. [europepmc]
• Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic. [europepmc]
• Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling. [europepmc]
• Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies. [europepmc]
• Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. [europepmc]
• SOD1 suppresses pro-inflammatory immune responses by protecting against oxidative stress in colitis. [europepmc]
• Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease: A Position Paper From the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition. [europepmc]
• Pathophysiology of Inflammatory Bowel Disease: Innate Immune System. [europepmc]